Contagion Editorial Team

Shionogi announces approval of cefiderocol for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

Join us tomorrow for an informative discussion on CDC guidance and insights from medical experts on navigating a way back to in-school learning.

A study suggests that both have similar cycle thresholds but the virus lays dormat in an overwhelming majority of asymptomatic patients.

MJH Life Sciences is presenting a webinar today on this important topic.

A discussion between providers on 3 studies related to the antiviral.

Gregory Felzien, MD, AAHIVS, discusses prevention beyond PrEP and creating a safe environment for patients with HIV.